# Influenza Vaccine in Pediatric Transplant Subjects

> **NCT00133510** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 60 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Trivalent Subviron Influenza vaccine (Fluzone)

## Key facts

- **NCT ID:** NCT00133510
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 60 (—)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133510, "Influenza Vaccine in Pediatric Transplant Subjects". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00133510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*